{
    "code": "02023925",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02023925",
    "time": "2023-11-24 16:04:51",
    "許可證字號": "衛署藥輸字第023925號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "118\/02\/17",
    "發證\/登錄日期": "93\/02\/17",
    "許可證\/登錄種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202392507",
    "中文品名": "舒得寧長效型注射凝膠劑120公絲",
    "英文品名": "SOMATULINE AUTOGEL 120MG PROLONGED RELEASE SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE",
    "適應症": "1.治療肢端肥大症，改善類癌瘤(CARCINOID TUMOURS)的臨床症狀。\r\n２、治療無法切除、分化程度為良好或中度、局部進展或轉移性之胃、腸、胰臟神經內分泌腫瘤(GEP-NETs)，以提升無惡化存活期(PFS) 。",
    "劑型": "277注射凝膠劑",
    "包裝": "一支注射針劑盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "LANREOTIDE (ACETATE)",
    "限制項目": "02輸　入",
    "申請商名稱": "法商益普生股份有限公司台灣分公司",
    "申請商地址": "台北市信義區松仁路89號13樓(D室)",
    "主製造廠": [
        {
            "製造廠名稱": "IPSEN PHARMA BIOTECH",
            "製造廠廠址": "PARC D&#39; ACTIVITES DU PLATEAU DE SIGNES, CD N 402-83870 SIGNES, FRANCE",
            "製造廠公司地址": "",
            "製造廠國別": "FRANCE",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "IPSEN PHARMA BIOTECH",
            "製造廠廠址": "ETABLISSEMENT GAMMASTER, MIN 712 ARNAVAUX, 13323 MARSEILLE CEDEX 14, FRANCE",
            "製造廠公司地址": "",
            "製造廠國別": "FRANCE",
            "製程": "放射線滅菌廠"
        },
        {
            "製造廠名稱": "IPSEN PHARMA",
            "製造廠廠址": "65 QUAI GEORGES GORSE, 92100 BOULOGNE-BILLANCOURT, FRANCE",
            "製造廠公司地址": "",
            "製造廠國別": "FRANCE",
            "製程": "許可證持有者"
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200036610",
            "成分名稱": "LANREOTIDE (ACETATE)",
            "含量描述": "",
            "含量": "120.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "外觀_SML_120mg 注射劑外觀-3-108-07-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023925&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "A02_Artwork_SML 120mg_201911-108-11-18.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023925&Seq=008&Type=8"
        }
    ]
}